LENSAR EPS - Earnings per Share 2019-2025 | LNSR
LENSAR eps - earnings per share from 2019 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| LENSAR Annual EPS | |
|---|---|
| 2024 | $-2.73 |
| 2023 | $-1.31 |
| 2022 | $-1.96 |
| 2021 | $-2.09 |
| 2020 | $-4.28 |
| 2019 | $-13.70 |
| 2018 | $-13.13 |
| LENSAR Quarterly EPS | |
|---|---|
| 2025-03-31 | $-2.32 |
| 2024-12-31 | $-1.62 |
| 2024-09-30 | $-0.13 |
| 2024-06-30 | $-0.79 |
| 2024-03-31 | $-0.19 |
| 2023-12-31 | $0.13 |
| 2023-09-30 | $-0.23 |
| 2023-06-30 | $-0.81 |
| 2023-03-31 | $-0.40 |
| 2022-12-31 | $-0.23 |
| 2022-09-30 | $-0.39 |
| 2022-06-30 | $-0.67 |
| 2022-03-31 | $-0.67 |
| 2021-12-31 | $-0.41 |
| 2021-09-30 | $-0.65 |
| 2021-06-30 | $-0.47 |
| 2021-03-31 | $-0.56 |
| 2020-12-31 | $4.00 |
| 2020-09-30 | $-0.64 |
| 2020-06-30 | $-4.20 |
| 2020-03-31 | $-3.44 |
| 2019-12-31 | $0.00 |
| 2019-09-30 | $-5.44 |
| 2018-12-31 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.156B | $0.053B |
| LENSAR Inc. is a commercial-stage medical device company. It focuses on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. LENSAR Inc. is based in Orlando, Florida. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $185.001B | 81.03 |
| Thermo Fisher Scientific (TMO) | United States | $160.427B | 19.41 |
| Edwards Lifesciences (EW) | United States | $44.687B | 29.30 |
| Alcon (ALC) | Switzerland | $42.893B | 28.99 |
| IDEXX Laboratories (IDXX) | United States | $41.716B | 47.94 |
| DexCom (DXCM) | United States | $32.976B | 50.97 |
| IQVIA Holdings (IQV) | United States | $28.242B | 15.82 |
| Mettler-Toledo (MTD) | United States | $25.057B | 29.80 |
| STERIS (STE) | Ireland | $22.093B | 24.33 |
| Waters (WAT) | United States | $17.669B | 24.93 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.026B | 0.00 |
| Hologic (HOLX) | United States | $14.267B | 15.50 |
| Sysmex ADR (SSMXY) | Japan | $10.575B | 30.00 |
| Penumbra (PEN) | United States | $8.911B | 69.94 |
| Masimo (MASI) | United States | $8.586B | 31.67 |
| Globus Medical (GMED) | United States | $7.791B | 18.57 |
| Glaukos (GKOS) | United States | $5.657B | 0.00 |
| Teleflex (TFX) | United States | $5.019B | 8.29 |
| Integer Holdings (ITGR) | United States | $4.000B | 20.96 |
| TransMedics (TMDX) | United States | $3.806B | 82.74 |
| PROCEPT BioRobotics (PRCT) | United States | $3.261B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.320B | 13.81 |
| Nihon Kohden (NHNKY) | Japan | $2.042B | 23.42 |
| Veracyte (VCYT) | United States | $1.897B | 26.61 |
| Elekta AB (EKTAY) | Sweden | $1.876B | 16.86 |
| Alphatec Holdings (ATEC) | United States | $1.554B | 0.00 |
| Artivion (AORT) | United States | $1.317B | 123.40 |
| OPKO Health (OPK) | United States | $1.094B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.053B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.023B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.931B | 4.95 |
| IRadimed (IRMD) | United States | $0.730B | 37.06 |
| SiBone (SIBN) | United States | $0.713B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.597B | 12.94 |
| Beta Bionics (BBNX) | United States | $0.571B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.550B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.538B | 8.37 |
| AxoGen (AXGN) | United States | $0.530B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.425B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.417B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.413B | 9.61 |
| Delcath Systems (DCTH) | United States | $0.394B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.364B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.355B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.319B | 0.00 |
| RxSight (RXST) | United States | $0.300B | 0.00 |
| NeuroPace (NPCE) | United States | $0.298B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.260B | 0.00 |
| Neuronetics (STIM) | United States | $0.253B | 0.00 |
| 908 Devices (MASS) | United States | $0.243B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.233B | 14.10 |
| CVRx (CVRX) | United States | $0.218B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.207B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.183B | 0.00 |
| Inogen (INGN) | United States | $0.180B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.170B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.151B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.130B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.123B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.113B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.112B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.092B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.092B | 0.00 |
| Hyperfine (HYPR) | United States | $0.080B | 0.00 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.073B | 44.40 |
| Spectral AI (MDAI) | United States | $0.068B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.060B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.058B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.058B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.052B | 21.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.023B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.021B | 0.00 | |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.42 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |